FDA Warning on Xylazine: Mitigating Human Risk | by: Sumeet Singh, Founder & Chairman | Article Posted: November 6, 2023 | The U.S. Food and Drug Administration (FDA) has issued a warning regarding mitigating risks from human Xylazine exposure. FDA has not...
OptumRx Network Policy: VAWD Requirement for Manufacturers and VDIP Accreditation By now, OptumRx’s VAWD Accreditation requirement has become a...
In 2018, legislation was passed in Iowa that required a company to have VAWD Accreditation as a prerequisite to being awarded wholesale drug distribution licensing, in line with three other states.
Teva Pharmaceuticals Earns VAWD Reaccreditation! We are excited to announce that our client, Teva Pharmaceuticals, was awarded VAWD® Reaccreditation...
NABP / Optum Rx VAWD Lawsuit Three generic drug wholesalers, Oak Drugs (“Oak”), Matrix Distributors (“Matrix”), and Primed Pharmaceuticals...
Post VAWD Requirement: Insight and Strategies After an eventful 27 months, OptumRx's VAWD requirement will likely be fully enforced on vendors of...
Optum Rx/VAWD Questions & Answers from July Webinar 1. Are there states other than NY that have legislation that makes it difficult for Optum to...
